MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE

MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE

Background: Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder of blood stem cells, which is typically characterized by the presence of a Philadelphia chromosome. Even though there have been several studies on the molecular genetics, pharmacogenomics, pharmacological treatments...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sameen Shahid, Muhammad Farooq Sabar, Zafar Iqbal, Muhammad Zafar Saleem, Muhammad Abbas Khokhar, Sana Ashiq
Format:	Article
Language:	English
Published:	Superior University Lahore, Pakistan 2024-03-01
Series:	International Journal of Pharmacy & Integrated Health Sciences
Subjects:	CML Drug Therapies TKIs Molecular Biology
Online Access:	https://ijpihs.pk/index.php/IJPIHS/article/view/121
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COVID-19 PANDEMIC AND CHRONIC MYELOID LEUKEMIA: A REVIEW
by: Hafiza Sidra Bashir, et al.
Published: (2022-10-01)

The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers
by: Anna Sicuranza, et al.
Published: (2025-05-01)

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

MUTATION ANALYSIS FOR NUCLEOPHOSMIN-1 (NPM1) GENE VARIANT OF CHRONIC MYELOID LEUKEMIA PATIENTS FROM LAHORE-PAKISTAN
by: Sumaira Mehboob, et al.
Published: (2025-03-01)

Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia
by: Ayesha Afzal, et al.
Published: (2024-11-01)

Hypercalcemia in Chronic Myeloid Leukemia: An Unusual Presentation
by: Khushboo Agarwal, et al.

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia
by: Hyun-Jin Kwon, et al.
Published: (2025-04-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01)

PRSS57 GENE EXPRESSION PREDICTS EARLY MOLECULAR RESPONSE FAILURE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
by: Elif Nur Bozdağ, et al.
Published: (2024-02-01)

An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib
by: Jovita Martin, et al.
Published: (2011-01-01)

The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature
by: Abdulrahman Al‐Abdulmalek, et al.
Published: (2023-03-01)

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
by: E. Agostani, et al.
Published: (2025-02-01)

Human immunodeficiency virus Infection in a patient of chronic myelogenous leukemia
by: Vijay B Tuljapurkar, et al.
Published: (2013-01-01)

Bilateral Hip Pain Caused by Adductor Pyomyositis as the Initial Presentation of Chronic Myeloid Leukemia in a 17-Year-Old Child
by: Ming-Chun Chen, et al.
Published: (2011-12-01)

The role of METTL14 in the progression of chronic myeloid leukemia
by: Jing Zhang, et al.
Published: (2025-12-01)

Mathematical modeling of cyclic treatments of chronic myeloid leukemia
by: Natalia L. Komarova
Published: (2011-03-01)

Evaluation of Electrolytes Disturbances in Iraqi Chronic Myeloid Leukemia Patients treated with Nilotinib with Monitoring of Response by FISH Study
by: Baghdad Science Journal
Published: (2015-03-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA
by: Buket Altinok Gunes, et al.
Published: (2023-01-01)

Isolated Central Nervous System Infiltrated and Progressed to Acute Myeloid Leukemia from Chronic Myeloid Leukemia with e1a3 BCR-ABL1 Transcript: A Rare Case Report and Literature Review
by: Qiang X, et al.
Published: (2025-01-01)

Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01)

Diagnostic and taxonomic challenges in chronic myelomonocytic leukemia with lymph node involvement: A case report and mini-review
by: Bhaumik Shah, et al.
Published: (2025-01-01)

Unveiling the Burden of Leukemia in Eritrea (2010–2020): Chronic Leukemia Stability, Rising ALL Incidence, and the Enigma of CML in a Low‐Resource Setting
by: Daniel Mebrahtu Abraha, et al.
Published: (2025-06-01)

Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response
by: Rebecca Warfvinge, et al.
Published: (2024-11-01)

DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms
by: Istemi SERIN, et al.
Published: (2021-02-01)

Unilateral sudden hearing loss as the first presenting symptom of chronic myeloid leukemia: a case report and literature review
by: Le Sun, et al.
Published: (2025-05-01)

Rare manifestations of pediatric chronic myeloid leukemia: a case report on priapism and a literature Review
by: Rawan Budair, et al.
Published: (2025-06-01)

STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2024-05-01)

CML with extrapulmonary tuberculosis with secondary HLH associated with deep vein thrombosis
by: Anindita Paul, et al.
Published: (2025-05-01)

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India
by: Rajiv Mohan, et al.
Published: (2025-07-01)

Beyond the Basics: Exploring Pharmacokinetic Interactions and Safety in Tyrosine-Kinase Inhibitor Oral Therapy for Solid Tumors
by: Laura Veronica Budău, et al.
Published: (2025-06-01)

Case Report of Chronic Myeloid Leukemia with Coexistent Sickle Cell Anemia Heterozygous Presentation
by: Bala Manideep Nuguri, et al.
Published: (2025-03-01)

Comparison of Socal Score and Hasford Score Against the Response of Imatinib Mesylate Therapy in Patients with Chronic Granulocytic Leukemia in dr. Saiful Anwar Hospital Malang
by: Somarnam, et al.
Published: (2019-12-01)

Acute vascular and cardiac effects of lenvatinib in mice
by: Dustin N. Krüger, et al.
Published: (2025-02-01)

Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01)

LC-Orbitrap-MS/MS Analysis of Chosen Glycation Products in Infant Formulas
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2025-06-01)

A COMPREHENSIVE REVIEW ON ASTHMA: PATHOPHYSIOLOGY, TREATMENT AND ROLE OF GENETICS
by: Muhammad Farooq Sabar, et al.
Published: (2023-09-01)

Myeloid sarcoma: Experience from a tertiary care center in southern India – A series of eight unusual cases
by: Roobashri Murugan, et al.
Published: (2025-01-01)

Mechanisms of Resistance in Non-Small Cell Lung Cancer
by: Alexandra-Maria HOZA, et al.
Published: (2023-12-01)